ACTAVIS SUBUTEX - AN OVERVIEW

The concomitant usage of buprenorphine and CYP3A4 inducers can decrease the plasma focus of buprenorphine [see CLINICAL PHARMACOLOGY], possibly causing diminished efficacy or onset of the withdrawal syndrome in sufferers who have formulated Actual physical dependence to buprenorphine.Caution people that SUBUTEX may perhaps impair the psychological